Barclays’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100
| Closed | – | – | 4479 |
|
|
2024
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 4426 |
|
|
2024
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 4385 |
|
|
2024
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 4261 |
|
|
2024
Q1 | $0 | Sell |
100
-255,085
| -100% | – | ﹤0.01% | 4233 |
|
|
2023
Q4 | $426K | Sell |
255,185
-390,305
| -60% | -$652K | ﹤0.01% | 3097 |
|
|
2023
Q3 | $2M | Sell |
645,490
-155,286
| -19% | -$481K | ﹤0.01% | 1671 |
|
|
2023
Q2 | $2.28M | Sell |
800,776
-46,052
| -5% | -$131K | ﹤0.01% | 1664 |
|
|
2023
Q1 | $3.34M | Buy |
846,828
+205,475
| +32% | +$809K | ﹤0.01% | 1313 |
|
|
2022
Q4 | $2.54M | Buy |
641,353
+100,771
| +19% | +$399K | ﹤0.01% | 1495 |
|
|
2022
Q3 | $4.97M | Buy |
540,582
+328,872
| +155% | +$3.02M | 0.01% | 1105 |
|
|
2022
Q2 | $1.3M | Sell |
211,710
-15,000
| -7% | -$92.2K | ﹤0.01% | 1885 |
|
|
2022
Q1 | $1.46M | Buy |
226,710
+23,697
| +12% | +$152K | ﹤0.01% | 2035 |
|
|
2021
Q4 | $1.33M | Buy |
203,013
+2,325
| +1% | +$15.2K | ﹤0.01% | 2035 |
|
|
2021
Q3 | $1.15M | Sell |
200,688
-3,213
| -2% | -$18.3K | ﹤0.01% | 2178 |
|
|
2021
Q2 | $1.12M | Buy |
203,901
+47,025
| +30% | +$259K | ﹤0.01% | 2048 |
|
|
2021
Q1 | $909K | Buy |
156,876
+119,561
| +320% | +$693K | ﹤0.01% | 2351 |
|
|
2020
Q4 | $250K | Hold |
37,315
| – | – | ﹤0.01% | 2612 |
|
|
2020
Q3 | $273K | Hold |
37,315
| – | – | ﹤0.01% | 2592 |
|
|
2020
Q2 | $141K | Buy |
37,315
+37,266
| +76,053% | +$141K | ﹤0.01% | 2981 |
|
|
2020
Q1 | $0 | Sell |
49
-851
| -95% | – | ﹤0.01% | 3827 |
|
|
2019
Q4 | $14K | Buy |
+900
| New | +$14K | ﹤0.01% | 3708 |
|